A Study of BL-M07D1 in Patients With Locally Advanced or Metastatic HER2-Positive/Negative Breast Cancer and Other Solid Tumors

Clinical trial NCT05461768 · RECRUITING

Trial details

NCT number: NCT05461768
Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Cancer Locally Advanced or Metastatic Solid Tumor

Start date: 2022-08-09
Primary completion: 2026-12-01
Enrollment: 348

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.